Hussein H. Aly
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
A synonymous mutation in the preS2 region enhances production of infectious hepatitis B virus.
Journal: Virology
Published: July 22, 2025
A novel synthetic bile acid derivative inhibits hepatitis B virus infection at entry step by interfering with the oligomerization of sodium taurocholate co-transporting polypeptide.
Journal: Antiviral research
Published: July 19, 2025
A novel synthetic bile acid derivative inhibits hepatitis B virus infection at entry step by interfering with the oligomerization of sodium taurocholate co-transporting polypeptide.
Journal: Antiviral research
Published: July 19, 2025
RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP trafficking.
Journal: Antiviral research
Published: April 21, 2025
Exploring the tolerable region for HiBiT tag insertion in the hepatitis B virus genome.
Journal: mSphere
Published: September 30, 2024
Antiviral effect of peptoids on hepatitis B virus infection in cell culture.
Journal: Antiviral research
Published: November 08, 2023
Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication.
Journal: Journal of virology
Published: October 06, 2023
Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review.
Journal: Viruses
Published: November 21, 2022
The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro.
Journal: PLoS pathogens
Published: September 25, 2021
Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virus.
Journal: Biochemical and biophysical research communications
Published: May 17, 2021
Last Updated: 09/26/2026